SCOPUS 정보 검색 플랫폼

Journal of the American College of Cardiology

Volumn 57, Issue 20, 2011, Pages 2035-2036

Cilostazol: A potential therapeutic option to prevent in-stent restenosis

(4) Dihu, Jamil B a Abudayyeh, Islam b Saudye, Hammad A b Gurujal, Ravi b

a ADVOCATE LUTHERAN GENERAL HOSPITAL (United States)

b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CILOSTAZOL;

ALGORITHM; ANGIOGRAPHY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG POTENCY; HUMAN; HYPERPLASIA; IN-STENT RESTENOSIS; INTERMITTENT CLAUDICATION; LETTER; PRIORITY JOURNAL; REVASCULARIZATION; RISK REDUCTION;

CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; PROSTHESIS FAILURE; TETRAZOLES;

EID: 79955848633 PISSN: 07351097 EISSN: None Source Type: Journal
DOI: 10.1016/j.jacc.2011.01.022 Document Type: Letter

Times cited : (10)

References (7)

1
- 78649365632
- In-stent restenosis in the drug-eluting stent era
- G.D. Dangas, B.E. Claessen, and A. Caixeta In-stent restenosis in the drug-eluting stent era J Am Coll Cardiol 56 2010 1897 1907
- (2010) J Am Coll Cardiol , vol.56 , pp. 1897-1907
- Dangas, G.D.¹ Claessen, B.E.² Caixeta, A.³

2
- 32944461243
- A scientific rationale for the CREST trial results: Evidence for the mechanism of action of cilostazol in restenosis
- DOI 10.1016/j.atherosclerosissup.2005.09.007, PII S1567568805000681
- R. Morishita A scientific rationale for the CREST trial results: evidence for the mechanism of action of cilostazol in restenosis Atheroscler Suppl 6 2005 41 46 (Pubitemid 43261539)
- (2005) Atherosclerosis Supplements , vol.6 , Issue.4 , pp. 41-46
- Morishita, R.¹

3
- 4644287449
- Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation
- DOI 10.1016/j.jacc.2004.06.066, PII S0735109704014421
- T. Inoue, T. Uchida, and M. Sakuma Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation J Am Coll Cardiol 44 2004 1408 1414 (Pubitemid 39303941)
- (2004) Journal of the American College of Cardiology , vol.44 , Issue.7 , pp. 1408-1414
- Inoue, T.¹ Uchida, T.² Sakuma, M.³ Imoto, Y.⁴ Ozeki, Y.⁵ Ozaki, Y.⁶ Hikichi, Y.⁷ Node, K.⁸

4
- 27844463244
- Coronary stent restenosis in patients treated with cilostazol
- DOI 10.1161/CIRCULATIONAHA.104.530097
- J.S. Douglas Jr., D.R. Holmes Jr., D.J. Kereiakes Cilostazol for Restenosis Trial (CREST) Investigators Coronary stent restenosis in patients treated with cilostazol Circulation 112 2005 2826 2832 (Pubitemid 41641677)
- (2005) Circulation , vol.112 , Issue.18 , pp. 2826-2832
- Douglas Jr., J.S.¹ Holmes Jr., D.R.² Kereiakes, D.J.³ Grines, C.L.⁴ Block, E.⁵ Ghazzal, Z.M.B.⁶ Morris, D.C.⁷ Liberman, H.⁸ Parker, K.⁹ Jurkovitz, C.¹⁰ Murrah, N.¹¹ Foster, J.¹² Hyde, P.¹³ Mancini, G.B.J.¹⁴ Weintraub, W.S.¹⁵

5
- 40749126089
- Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus: The DECLARE-DIABETES trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation in Diabetic Patients)
- S.W. Lee, S.W. Park, and Y.H. Kim Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus: the DECLARE-DIABETES trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients) J Am Coll Cardiol 51 2008 1181 1187
- (2008) J Am Coll Cardiol , vol.51 , pp. 1181-1187
- Lee, S.W.¹ Park, S.W.² Kim, Y.H.³

6
- 34548633702
- Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial)
- S.W. Lee, S.W. Park, and Y.H. Kim Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial) Am J Cardiol 100 2007 1103 1108
- (2007) Am J Cardiol , vol.100 , pp. 1103-1108
- Lee, S.W.¹ Park, S.W.² Kim, Y.H.³

7
- 70349787228
- Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: A meta-analysis of randomised controlled trials
- U. Tamhane, P. Meier, and S. Chetcuti Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials EuroIntervention 5 2009 384 393
- (2009) EuroIntervention , vol.5 , pp. 384-393
- Tamhane, U.¹ Meier, P.² Chetcuti, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.